Vascular endothelial growth factor (VEGF) fails to improve blood flow and to promote collateralization in a diabetic mouse ischemic hindlimb model
<p>Abstract</p> <p>Background</p> <p>Angiogenic therapy with vascular endothelial growth factor (VEGF) has been proposed as a treatment paradigm for patients suffering from an insufficiency of collateral vessels. Diabetes is associated with increase in the production of...
Main Authors: | Abassi Zaid A, Levy Nina S, Avivi Aaron, Nevo Eviatar, Rubinstein Irit, Nitecki Samy, Roguin Ariel, Sabo Edmond, Lache Orit, Frank Meira, Hoffman Aaron, Levy Andrew P |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2003-12-01
|
Series: | Cardiovascular Diabetology |
Subjects: | |
Online Access: | http://www.cardiab.com/content/2/1/18 |
Similar Items
-
Sex Differences in Collateral Remodeling Following Hindlimb Arterial Occlusion
by: Burckhardt, Laura
Published: (2017) -
Collateral choice option valuation
by: Mollaret, Sébastian
Published: (2015) -
The dynamics of monocytes in the process of collateralization
by: Long‐Sheng Liao, et al.
Published: (2019-03-01) -
Post-Glenn Shunt Systemic Desaturation—Is Venovenous Collateral the Culprit?
by: Hemanth Harish Ponnana, et al.
Published: (2020-06-01) -
The „Collateral Estoppel” Theory in International Law
by: Claudia ANDRIŢOI
Published: (2011-08-01)